Form 4: Vivek Garipalli Increases Stake in Clover Health Investments, Corp.

Sentiment:

SEC Form 4


Vivek Garipalli, a director and 10% owner of Clover Health Investments, Corp., purchased 531,700 shares of Class A Common Stock at an average price of $1.88 on August 9, 2024.

Summary

  • On August 9, 2024, Vivek Garipalli, a director and 10% owner of Clover Health Investments, Corp., acquired 531,700 shares of Class A Common Stock.
  • The shares were purchased at a weighted average price of $1.88.
  • The transactions occurred at prices ranging from $1.84 to $1.91.
  • Following the transaction, Garipalli directly owns 1,409,267 shares of Clover Health Investments, Corp.

Sentiment

Score: 6

Explanation: Insider buying is generally viewed as a positive sign, but the overall impact depends on the size of the purchase relative to the insider's existing holdings and the company's market capitalization.

Positives

  • The purchase by a director and significant shareholder could be interpreted as a positive signal about the company's prospects.

Industry Context

Insider buying is often seen as a positive sign, suggesting that those with the most knowledge of the company's prospects are optimistic about its future. However, it's important to consider the overall context of the company's performance and industry trends.

Key Dates

DateDescription
08/09/2024Date of transaction: Vivek Garipalli purchased shares of CLOV.
08/13/2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.